D. Grimaldi, A. Silvani, E. E. Benarroch, and P. Cortelli, Orexin/hypocretin system and autonomic control: new insights and clinical correlations, Neurology, vol.82, pp.271-278, 2014.

G. Plazzi, K. K. Moghadam, and L. S. Maggi, Autonomic disturbances in narcolepsy, Sleep Med Rev, vol.15, pp.187-196, 2011.

J. Boggia, Y. Li, and L. Thijs, Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study, Lancet, vol.370, pp.1219-1229, 2007.

T. W. Hansen, J. Jeppesen, and S. Rasmussen, Ambulatory blood pressure and mortality: a population-based study, Hypertension, vol.45, pp.499-504, 2005.

R. C. Hermida, D. E. Ayala, and M. H. Smolensky, Sleep-time blood pressure: sensitive and unique prognostic marker of vascular risk and therapeutic target for prevention, Sleep Med Rev, vol.33, pp.17-27, 2017.

T. Ohkubo, A. Hozawa, and J. Yamaguchi, Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study, J Hypertens, vol.20, pp.2183-2189, 2002.

Y. Dauvilliers, I. Jaussent, and B. Krams, Non-dipping blood pressure profile in narcolepsy with cataplexy, PLoS One, vol.7, p.38977, 2012.

V. Donadio, R. Liguori, and S. Vandi, Sympathetic and cardiovascular changes during sleep in narcolepsy with cataplexy patients, Sleep Med, vol.15, pp.315-321, 2014.

D. Grimaldi, G. Calandra-buonaura, and F. Provini, Abnormal sleep-cardiovascular system interaction in narcolepsy with cataplexy: effects of hypocretin deficiency in humans, Sleep, vol.35, pp.519-528, 2012.

S. Bastianini, A. Silvani, and C. Berteotti, Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice, Sleep, vol.34, pp.213-218, 2011.

V. Donadio, R. Liguori, and S. Vandi, Lower wake resting sympathetic and cardiovascular activities in narcolepsy with cataplexy, Neurology, vol.83, pp.1080-1086, 2014.

F. Poli, G. Plazzi, D. Dalmazi, and G. , Body mass index-independent metabolic alterations in narcolepsy with cataplexy, Sleep, vol.32, pp.1491-1497, 2009.

A. Schuld, J. Hebebrand, F. Geller, and T. Pollmächer, Increased body-mass index in patients with narcolepsy, Lancet, vol.355, pp.1274-1275, 2000.

L. Barateau, R. Lopez, and Y. Dauvilliers, Treatment options for narcolepsy, CNS Drugs, vol.30, pp.369-379, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01484941

M. V. Solanto, Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration, Behav Brain Res, vol.94, pp.127-152, 1998.

J. E. Ballard, R. A. Boileau, and E. K. Sleator, Cardiovascular responses of hyperactive children to methylphenidate, JAMA, vol.236, pp.2870-2874, 1976.

G. Stiefel and F. Besag, Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder, Drug Saf, vol.33, pp.821-842, 2010.

B. Vitiello, G. R. Elliott, and J. M. Swanson, Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD, Am J Psychiatry, vol.169, pp.167-177, 2012.

C. D. Stowe, S. F. Gardner, and C. C. Gist, 24-Hour ambulatory blood pressure monitoring in male children receiving stimulant therapy, Ann Pharmacother, vol.36, pp.1142-1149, 2002.

L. A. Habel, W. O. Cooper, and C. M. Sox, ADHD medications and risk of serious cardiovascular events in young and middle-aged adults, JAMA, vol.306, pp.2673-2683, 2011.

T. E. Wilens, P. G. Hammerness, and J. Biederman, Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder, J Clin Psychiatry, vol.66, pp.253-259, 2005.

W. O. Cooper, L. A. Habel, and C. M. Sox, ADHD drugs and serious cardiovascular events in children and young adults, N Engl J Med, vol.365, pp.1896-1904, 2011.

P. Jennum, R. Ibsen, S. Knudsen, and J. Kjellberg, Comorbidity and mortality of narcolepsy: a controlled retro-and prospective national study, Sleep, vol.36, pp.835-840, 2013.

M. M. Ohayon, Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population, Sleep Med, vol.14, pp.488-492, 2013.

, American Academy of Sleep Medicine. International Classification of Sleep Disorders-Third Edition, 2014.

G. Mancia, R. Fagard, and K. Narkiewicz, ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Blood Press, vol.22, pp.193-278, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02042310

M. Johns, A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale, Sleep, vol.14, pp.540-545, 1991.

R. Rubinshtein, J. T. Kuvin, and M. Soffler, Assessment of endothelial function by noninvasive peripheral arterial tonometry predicts late cardiovascular adverse events, Eur Heart J, vol.31, pp.1142-1148, 2010.

D. L. Clement, D. Buyzere, M. L. , D. Bacquer, and D. A. , Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension, N Engl J Med, vol.348, pp.2407-2415, 2003.

T. W. Hansen, Y. Li, and J. Boggia, Predictive role of the nighttime blood pressure, Hypertension, vol.57, pp.3-10, 2011.

S. L. Stevens, S. Wood, and C. Koshiaris, Blood pressure variability and cardiovascular disease: systematic review and meta-analysis, BMJ, vol.354, p.4098, 2016.

D. Grimaldi, G. Pierangeli, and G. Barletta, Spectral analysis of heart rate variability reveals an enhanced sympathetic activity in narcolepsy with cataplexy, Clin Neurophysiol, vol.121, pp.1142-1147, 2010.

M. T. Cooney, E. Vartiainen, and T. Laakitainen, Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women, Am Heart J, vol.159, pp.612-619, 2010.

S. Lewington, R. Clarke, and N. Qizilbash, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, vol.360, pp.1903-1913, 2002.

F. D. Fuchs, Prehypertension: the rationale for early drug therapy, Cardiovasc Ther, vol.28, pp.339-343, 2010.

J. Pepin, A. Borel, and R. Tamisier, Hypertension and sleep: overview of a tight relationship, Sleep Med Rev, vol.18, pp.509-519, 2014.

M. J. Thorpy and Y. Dauvilliers, Clinical and practical considerations in the pharmacologic management of narcolepsy, Sleep Med, vol.16, pp.9-18, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02164813

Y. Dauvilliers, I. Arnulf, and E. Mignot, Narcolepsy with cataplexy, Lancet, vol.369, pp.499-511, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00534816

V. K. Somers, M. E. Dyken, A. L. Mark, and F. M. Abboud, Sympathetic-nerve activity during sleep in normal subjects, N Engl J Med, vol.328, pp.303-307, 1993.

V. L. Vetter, J. Elia, and C. Erickson, Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing, Circulation, vol.117, pp.2407-2423, 2008.